Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study - Top-Institutions - MDSpire

Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study

  • By

  • Theresa Klinger

  • Katharina Müller

  • Ricarda Graf

  • Matthias Augustin

  • Kristina Hagenström

  • June 22, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Icahn School of Medicine at Mount Sinai / Mount Sinai Health System
    Icahn School of Medicine at Mount Sinai / Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Dermatology

  • #2

    Brigham and Women’s Hospital, Harvard Medical School
    Brigham and Women’s Hospital, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Dermatology

  • #3

    Danish National Prescription Registry
    Danish National Prescription Registry

    Copenhagen, Denmark

    Key Differentiators

    • Pharmacy

  • #4

    Swedish Prescribed Drug Registry
    Swedish Prescribed Drug Registry

    Stockholm, Sweden

    Key Differentiators

    • Pharmacy

  • #5

    Clinical Practice Research Datalink (CPRD)
    Clinical Practice Research Datalink (CPRD)

    London, UK

    Key Differentiators

    • Clinical Research

Original Source(s)

Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study

  • by Theresa Klinger, Katharina Müller, Ricarda Graf, Matthias Augustin, Kristina Hagenström

  • June 22, 2026

Related Content

Evaluation of Cardiovascular Risk Factors Among Adults With Perinatally Acquired HIV

Corticosteroid-Associated Adverse Events in Chronic Spontaneous Urticaria: A US Claims Data Study

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.